Plot No.367, Abhey Pur, Industrial Area Phase-1, Panchkula, Haryana 134109
Don't miss out on this limited-time offer to join our successful PCD Pharma network. Fill in your details below and our team will get in touch with you to discuss the best franchise opportunities tailored to your needs.
Deflazacort (6mg/5ml)
Therapeutic Category
Anti-Inflammatories, Asthma, General and OTC medicines, Immunology, Pediatrics
Dosage Form
Suspension
Packaging Type
With Carton
Packaging
30ml
Price
₹92/-
High-resolution images and Product visuals
Product overview and usage information
Detailed information and research documents
Defziff Oral Suspension is a corticosteroid formulation designed to provide effective management of various inflammatory and autoimmune conditions. With its active ingredient, deflazacort, this suspension offers a potent anti-inflammatory effect, making it suitable for treating conditions such as rheumatoid arthritis, systemic lupus erythematosus, and certain types of dermatitis. Its formulation is particularly beneficial for patients requiring a liquid form of medication, ensuring easy administration for children and individuals who may have difficulty swallowing tablets.
Deflazacort works by suppressing the immune system’s inflammatory response, thereby alleviating symptoms such as pain, swelling, and redness. It is also indicated for use in certain acute allergic reactions and as an adjunctive treatment for specific cancers. This medication allows patients to lead a more comfortable life by reducing the severity of their symptoms and improving overall quality of life.
side effects may include gastrointestinal disturbances, weight gain, and mood changes. Long-term use may lead to more serious complications, such as adrenal suppression or increased risk of infections. Patients should be closely monitored by healthcare providers to manage these risks effectively.
Defziff Oral Suspension is indicated for the treatment of: Inflammatory conditions like rheumatoid arthritis Autoimmune disorders (e.g., lupus, vasculitis) Allergic reactions Asthma exacerbations Inflammatory bowel disease
Consult your healthcare provider before use, especially if you have underlying health conditions or are taking other medications. In summary, Defziff Oral Suspension provides a vital treatment option for managing a variety of inflammatory and autoimmune conditions. Its convenient liquid form facilitates easier administration, particularly for younger patients or those with swallowing difficulties. Always follow the guidance of a healthcare professional when using this medication to ensure safe and effective treatment.
Store at room temperature, away from direct sunlight and moisture. Keep out of reach of children.
Composition : Fluticasone Furoate (27.5mcg)
Composition : Fluticasone Furoate (27.5mcg) + Azelastine (140mcg)
Composition : Mometasone (50mcg)
Composition : Formoterol (6mcg) + Fluticasone Propionate (250mcg)
Composition : Formoterol (6mcg) + Budesonide (400mcg) Inhaler
Composition : Formoterol (6mcg) + Budesonide (200mcg) Inhaler
Composition : Fluticasone Furoate (50mcg)
This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.
Deflazacort 6mg/5ml Suspension has strong demand in the pediatric anti-inflammatory and immunosuppressant segment, making it a high-potential product for medical distributors, wholesalers, and pharma franchise partners looking to expand in the PCD pharma pharma franchise market.
Medical distributors and wholesalers can benefit from consistent demand in pediatric inflammatory conditions, allergic disorders, respiratory illnesses, and autoimmune conditions under medical supervision. It strengthens their pediatric and general medicine portfolio.
Yes, Cafoli Lifecare offers PCD pharma pharma franchise opportunities for Deflazacort 6mg/5ml Suspension with monopoly rights, quality packaging, competitive pricing, and reliable supply support for distributors and medical agencies.
Wholesalers and medical agencies benefit from steady prescription demand, repeat pediatric usage, and strong market acceptance in pediatric and respiratory care segments when partnering with Cafoli Lifecare.
Medical distributors, stockists, wholesalers, and pharma professionals interested in this pediatric corticosteroid formulation can contact Cafoli Lifecare to discuss PCD pharma franchise opportunities, bulk procurement, pricing details, and distribution support services.